 - Other life-threatening illness, any medical condition, or organ system dysfunction, which, in the opinion of the Investigator and Sponsor, would either compromise the patients safety or interfere with evaluation of the safety of ridaforolimus, or could interfere with the absorption of the oral study drug. 